-
公开(公告)号:US4784855A
公开(公告)日:1988-11-15
申请号:US61973
申请日:1987-06-15
IPC分类号: A61K9/02 , A61K31/485 , A61K47/34 , A61F9/02
CPC分类号: A61K9/02 , A61K31/485 , Y10S424/15
摘要: A pharmaceutical composition for suppository which comprises buprenorphine or its pharmaceutically acceptable acid addition salt as the active ingredient and a mixed base composed of 70 to 95 wt. % of polyethylene glycol with average molecular weight of 200 to 20,000 and 30 to 5 wt. % of propylene glycol.
摘要翻译: 一种用于栓剂的药物组合物,其包含丁丙诺啡或其药学上可接受的酸加成盐作为活性成分,和由70〜95重量% %的平均分子量为200〜20,000的聚乙二醇和30〜5重量% %的丙二醇。